CLINICAL_TRIALS ClinicalTrials.gov record update

Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion: a Randomized Phase II Biomarker Trial in Subjects at Increased Risk

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06033092
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:23.752055+00:00
Published At: 2025-08-28T00:00:00+00:00
Record Updated At: 2025-08-28
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["BRCA Mutation", "PALB2 Gene Mutation", "Ductal Carcinoma in Situ", "Lobular Carcinoma in Situ", "ATM Gene Mutation", "CHEK2 Gene Mutation", "CDH1 Gene Mutation", "RAD51C Gene Mutation", "RAD51D Gene Mutation"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-08-28"
protocolSection.identificationModule.nctId: "NCT06033092"
protocolSection.identificationModule.officialTitle: "Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion: a Randomized Phase II Biomarker Trial in Subjects at Increased Risk"
protocolSection.statusModule.overallStatus: "ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.